DE60210101D1 - Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten - Google Patents

Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten

Info

Publication number
DE60210101D1
DE60210101D1 DE60210101T DE60210101T DE60210101D1 DE 60210101 D1 DE60210101 D1 DE 60210101D1 DE 60210101 T DE60210101 T DE 60210101T DE 60210101 T DE60210101 T DE 60210101T DE 60210101 D1 DE60210101 D1 DE 60210101D1
Authority
DE
Germany
Prior art keywords
hairfollicles
neurokinin
treatment
receptor antagonists
follicles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60210101T
Other languages
English (en)
Other versions
DE60210101T2 (de
Inventor
Ralf Paus
Clara Arck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Cutech SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cutech SRL filed Critical Cutech SRL
Application granted granted Critical
Publication of DE60210101D1 publication Critical patent/DE60210101D1/de
Publication of DE60210101T2 publication Critical patent/DE60210101T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
DE60210101T 2001-07-23 2002-07-17 Behandlung von Haarfollikeln insbesondere gegen Haarausfall Expired - Fee Related DE60210101T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2001PD000187A ITPD20010187A1 (it) 2001-07-23 2001-07-23 Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
ITPD20010187 2001-07-23
PCT/EP2002/007963 WO2003009898A1 (en) 2001-07-23 2002-07-17 Treatment of hair follicle with neurokinin 1 receptor antagonists

Publications (2)

Publication Number Publication Date
DE60210101D1 true DE60210101D1 (de) 2006-05-11
DE60210101T2 DE60210101T2 (de) 2006-12-21

Family

ID=11452426

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210101T Expired - Fee Related DE60210101T2 (de) 2001-07-23 2002-07-17 Behandlung von Haarfollikeln insbesondere gegen Haarausfall

Country Status (9)

Country Link
US (1) US20050063931A1 (de)
EP (1) EP1414524B1 (de)
JP (1) JP2005506966A (de)
AT (1) ATE320832T1 (de)
AU (1) AU2002321232A1 (de)
DE (1) DE60210101T2 (de)
ES (1) ES2261704T3 (de)
IT (1) ITPD20010187A1 (de)
WO (1) WO2003009898A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8182473B2 (en) 1999-01-08 2012-05-22 Palomar Medical Technologies Cooling system for a photocosmetic device
US6517532B1 (en) 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
WO1998051235A1 (en) 1997-05-15 1998-11-19 Palomar Medical Technologies, Inc. Method and apparatus for dermatology treatment
EP1062001B1 (de) 1998-03-12 2005-07-27 Palomar Medical Technologies, Inc. System zur elektromagnetischen bestrahlung der haut
EP1539013A4 (de) 2002-06-19 2005-09-21 Palomar Medical Tech Inc Verfahren und gerät zur behandlung von haut- und unterhauterkrankungen
KR20050071618A (ko) 2002-10-23 2005-07-07 팔로마 메디칼 테크놀로지스, 인코포레이티드 냉각제 및 국소용 물질과 함께 사용하기 위한 광처리 장치
US7856985B2 (en) 2005-04-22 2010-12-28 Cynosure, Inc. Method of treatment body tissue using a non-uniform laser beam
EP1922008A2 (de) * 2005-08-08 2008-05-21 Palomar Medical Technologies, Inc. Augensichere photokosmetische vorrichtung
CN101309631A (zh) * 2005-09-15 2008-11-19 帕洛玛医疗技术公司 皮肤光学表征设备
US7586957B2 (en) 2006-08-02 2009-09-08 Cynosure, Inc Picosecond laser apparatus and methods for its operation and use
US20100286673A1 (en) * 2008-03-17 2010-11-11 Palomar Medical Technologies, Inc. Method and apparatus for treatment of tissue
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
KR102342629B1 (ko) 2012-04-18 2021-12-22 싸이노슈어, 엘엘씨 피코초 레이저 장치 및 그를 사용한 표적 조직의 치료 방법
EP3751684A1 (de) 2013-03-15 2020-12-16 Cynosure, Inc. Optische picosekunden-strahlungssysteme und verfahren zur verwendung
AU2019225242B2 (en) 2018-02-26 2023-08-10 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728166A1 (fr) * 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
ATE219928T1 (de) * 1995-02-28 2002-07-15 Gillette Co Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses
FR2740040B1 (fr) * 1995-10-23 1997-12-05 Oreal Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p
US5972938A (en) * 1997-12-01 1999-10-26 Merck & Co., Inc. Method for treating or preventing psychoimmunological disorders
AU2002259147A1 (en) * 2001-05-08 2002-11-18 Schering Corporation Use of neurokinin receptor antagonists to treat androgen-dependent diseases

Also Published As

Publication number Publication date
JP2005506966A (ja) 2005-03-10
WO2003009898A8 (en) 2003-03-20
EP1414524B1 (de) 2006-03-22
WO2003009898A1 (en) 2003-02-06
EP1414524A1 (de) 2004-05-06
DE60210101T2 (de) 2006-12-21
ES2261704T3 (es) 2006-11-16
ATE320832T1 (de) 2006-04-15
US20050063931A1 (en) 2005-03-24
AU2002321232A1 (en) 2003-02-17
ITPD20010187A1 (it) 2003-01-23

Similar Documents

Publication Publication Date Title
DE60210101D1 (de) Behandlung von haarfollikeln mit neurokinin 1 rezeptor antagonisten
ATE350060T1 (de) Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten
ATE387215T1 (de) Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff
ATE494884T1 (de) Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält
ATE204164T1 (de) Pflaster zur behandlung von nagelmykosen
DE69507029D1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
NO20025450D0 (no) Ny farmasöytisk sammensetning
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
NO960630D0 (no) Heterocykler anvendelige som neurokinin antagonister
CY1113312T1 (el) Κυκλικοι αναστολεις κινασης τυροσινης πρωτεϊνων
TR200001312T2 (tr) Benzotiyazol protein tirozin kinaz önleyicileri.
NO983003L (no) Vitronectin-reseptor-antagonister
DE69616375D1 (de) Nicht-allosterische GABA A Agonisten zur Behandlung von Schlafstörungen
ATE304523T1 (de) Trisubstituierte-n-((1s)-1,2,3,4-tetrahydro-1- naphthalenyl) benzamide welche p2x3 und p2x2/3 enthaltende rezeptoren inhibieren
EA200400734A1 (ru) Способ и композиция для потенциирования действия опиатного анальгетика
DK0615751T3 (da) Anvendelse af tachykininantagonister til behandling af emesis
DE60228317D1 (de) N-aryl-n'-arylcycloalkyl-harnstoff als mch antagonisten zur behandlung von fettleibigkeit
ATE406159T1 (de) Behandlung von hyperlipidämie
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
BR9813797A (pt) Processo para tratar glaucoma de glc1a, e, composição para controlar glaucoma de glc1a.
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE301474T1 (de) Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten
EE200100520A (et) N-(2-fenüül-4-aminobutüül)-1-naftamiidid neurokiniin-1-retseptori antagonistidena
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
DE69731658D1 (de) Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HENKEL AG & CO. KGAA, 40589 DUESSELDORF, DE

8339 Ceased/non-payment of the annual fee